Skip to main content

and
  1. No Access

    Article

    Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

    Although increased levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) have been associated with cardiac disease, whether this enzyme has a causal role in the development of atherosclerosis has not bee...

    Robert L Wilensky, Yi Shi, Emile R Mohler III, Damir Hamamdzic in Nature Medicine (2008)